Publications

5891 Results

Maintenance BCG immunotherapy: Evidence of additional protection against cancer. A Southwest Oncology Group study.

Authors
DL Lamm;JD Crissman;JE Montie;JE Gottesman;BA Lowe;MF Sarosdy;RD Bohl;HB Grossman;TM Beck;JT Leimert;ED Crawford;U Kosecka;RC Wittes
Journal / Conference
Proc of the American Urological Association :#1464
Year
1999
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8507

Phase II evaluation of cisplatin + 5-fluorouracil + radiation therapy in patients with locally advanced/inoperable bladder cancer. A Southwest Oncology Group study 9312.

Authors
M Hussain;E Fisher;J Forman;W Sakr;A Drelichman;S Akhter;HB Grossman;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 18:333a(#1281)
Year
1999
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9312

Long-term survival after concurrent cisplatin/etoposide (PE) plus chest radiotherapy (RT) followed by surgery in bulky, stages IIIA(N2) and IIIB non-small cell lung cancer (NSCLC): 6-year outcomes from Southwest Oncology Group Study 8805.

Authors
K Albain;V Rusch;J Crowley;T Rice;T Turrisi;J Weick;V Lonchyna;C Presant;R McKenna;D Gandara;H Fosmire;S Taylor;K Stelzer;K Beasley;R Livingston
Journal / Conference
Proc of the American Society of Clinical Oncology 18:467a(#1801)
Year
1999
Research Committee(s)
Lung
Study Number(s)
SWOG-8805

Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: An intergroup study of the National Cancer Institute of Canada Clinical trials group and the Southwest Oncology Group.

Authors
N Murray;RB Livingston;FA Shepherd;K James;B Zee;A Langleben;M Kraut;J Bearden;JW Goodwin;C Grafton;A Turrisi;D Walde;H Croft;J Ottaway;D Gandara
Journal / Conference
Journal of Clinical Oncology 17(8):2300-2308
Year
1999
Research Committee(s)
Lung
Study Number(s)
SWOG-9216 (INT-0131) (NCIC-CTG-BR.8)

SWOG 95-01: A phase II trial of a combination of fludarabine and mitoxantrone (FN) in untreated advanced low grade lymphoma. An effective, well tolerated therapy.

Authors
W Velasquez;D Lew;T Miller;R Fisher
Journal / Conference
Proc of the American Society of Clinical Oncology 18:9a(#27)
Year
1999
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9501

Carboplatin and paclitaxel (CARBO/TAX) for advanced transitional cell carcinoma (TCC) of the urothelium.

Authors
EJ Small;D Lew;DP Petrylak;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 18:333a(#1280)
Year
1999
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9457

Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-a for advanced renal cell carcinoma. A Southwest Oncology Group study.

Authors
L Elias;D Lew;RA Figlin;RC Flanigan;ME Thompson;PL Triozzi;RJ Belt;DP Wood;SE Rivkin;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 18:331a(#1275)
Year
1999
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9338

Preliminary toxicity results from Southwest Oncology Group trial (SWOG) 9705: A phase II trial of cisplatin, etoposide and paclitaxel (PET) with G-CSF in untreated patients (PTS) with extensive small cell lung cancer (SCLC).

Authors
PA Bunn;K Kelly;J Crowley;RB Livingston;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 18:468a(#1807)
Year
1999
Research Committee(s)
Lung
Study Number(s)
S9705

A randomized phase III trial of paclitaxel plus carboplatin (PC) versus vinorelbine plus cisplatin (VC) in untreated advanced non-small cell lung cancer (NSCLC): A Southwest Oncology Group (SWOG) trial.

Authors
K Kelly;J Crowley;PA Bunn;RB Livingston;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 18:461a(#1777)
Year
1999
Research Committee(s)
Lung
Study Number(s)
SWOG-9509

Preliminary analysis of the E1690/S9111/C9190 intergroup postoperative adjuvant trial of high-and low- dose IFNa2b (HDI and LDI) in high-risk primary or lymph node metastatic melanoma.

Authors
JM Kirkwood;J Ibrahim;V Sondak;M Ernstoff;L Flaherty;T Smith;J Richards;U Rao;M Steele;R Blum
Journal / Conference
Proc of the American Society of Clinical Oncology 18:537a(#2072)
Year
1999
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9111 (EST-1690)